Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Other Non Operating Income (2016 - 2025)

Wave Life Sciences' Other Non Operating Income history spans 11 years, with the latest figure at $234000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 90.82% year-over-year to $234000.0; the TTM value through Dec 2025 reached $527000.0, down 83.69%, while the annual FY2025 figure was $527000.0, 83.69% down from the prior year.
  • Other Non Operating Income reached $234000.0 in Q4 2025 per WVE's latest filing, down from $324000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.5 million in Q4 2024 to a low of -$701000.0 in Q3 2022.
  • Average Other Non Operating Income over 5 years is $509050.0, with a median of $330500.0 recorded in 2024.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 337.8% in 2024, then crashed 355.56% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at $1.1 million in 2021, then plummeted by 125.99% to -$290000.0 in 2022, then surged by 300.69% to $582000.0 in 2023, then skyrocketed by 337.8% to $2.5 million in 2024, then plummeted by 90.82% to $234000.0 in 2025.
  • Per Business Quant, the three most recent readings for WVE's Other Non Operating Income are $234000.0 (Q4 2025), $324000.0 (Q3 2025), and -$82000.0 (Q2 2025).